|
American Medical Association |
AMA STEPSFORWARD - Saving Time: Practice Innovation Boot Camp - September 2025 |
9 |
Yes |
10/29/2025 |
|
JAMA Neurology |
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020 |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Early Adoption of AntiSARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022 |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Geographic Accessibility of COVID-19 Test to Treat Sites by Race, Ethnicity, Age, and Rurality |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution |
1 |
Yes |
11/14/2025 |
|
University of Missouri School of Medicine |
MO Coalition Against Domestic & Sexual Violence |
2 |
No |
11/14/2025 |
|
JAMA Network Open |
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018 |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children |
1 |
Yes |
11/14/2025 |
|
JAMA Psychiatry |
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections |
1 |
Yes |
11/14/2025 |
|
JAMA Internal Medicine |
Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19 Associated Venous Thromboembolism |
1 |
Yes |
11/14/2025 |
|
Clinical Care Options, LLC |
Pioneering Pathways: New and Emerging Agents for Schizophrenia |
1 |
No |
11/15/2025 |
|
JAMA Cardiology |
Primary Prevention Management of Elevated Lipoprotein(a) |
1 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 1: Risk Implications |
0.5 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 2: Risk Assessment |
0.5 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 3: Prevention |
0.5 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 4: External Maneuvers |
0.5 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 5: Internal Maneuvers |
0.5 |
Yes |
11/16/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Shoulder Dystocia Part 6: Safety |
0.5 |
Yes |
11/16/2025 |
